10 stories found
Several companies, including Recruit Holdings, Daimler Truck, Arteris, and ICU Medical, have updated or raised their financial outlooks for fiscal year 2026. These revisions reflect various factors such as strong performance, strategic initiatives, and market conditions.
This article provides the full transcript of LifeMD's (LFMD) first-quarter 2026 earnings call.
Smithfield Foods, Inc. has announced a dividend of $0.3125 per share.
LifeMD has outlined a target of achieving over $250 million in annualized revenue run rate by the fourth quarter of 2026, driven by record demand for GLP-1 drugs and expanded partnerships.
Several companies, including Bruker, Lifemd, Carter's, and Clean Harbors, have reaffirmed their financial guidance and outlooks for the 2026 fiscal year. These projections include targets for revenue, adjusted EBITDA, and earnings per share.
Several companies, including Crexendo, EQT, and Ally Financial, have announced or reported their financial results for the first quarter of 2026. These reports include details on earnings per share and revenue performance.
LifeMD has announced the appointment of Atul Kavthekar as its new Chief Financial Officer. Following the news, the company's shares experienced an uptick.
LifeMD announced the highlights from its first-quarter earnings call, providing an overview of its financial results and strategic initiatives.
Novo Nordisk has introduced multi-month subscription plans for its obesity drug, Wegovy, offering lower monthly pricing and expanding sales channels to include platforms like Hims and LifeMD to compete with rivals.
LifeMD shares surged following reports that Cantor Fitzgerald reiterated its Overweight rating on the company after a strong Q4 earnings report.